Brain Sentinel
11
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.1%
1 terminated/withdrawn out of 11 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a Recent Non-diagnostic EMU Visit
Role: lead
Detecting PNES With Single-channel sEMG
Role: lead
An Exploratory Trial Using sEMG to Differentiate PNES From Epileptic Seizures
Role: lead
Clinical Utility of the SPEAC® System: A Case Series
Role: lead
Automated Identification of Psychogenic Nonepileptic Seizures
Role: lead
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis
Role: lead
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs
Role: lead
Seizure Detection and Warning System for Epilepsy Patients
Role: lead
Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
Role: lead
Seizure Detection and Warning System in Epilepsy Patients
Role: lead
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
Role: lead
All 11 trials loaded